← Back to writing
    newsletterlongevityhealthspanin-practice

    What to measure before starting a new treatment

    BASELINE TESTING

    The tests worth doing before starting a new treatment.

    Starting a GLP-1 or a new metabolic molecule without baseline data is risky. Baseline data guides the first dose and later changes.

    • 01Resting metabolic rate, measured directly. Most calculators use height and weight to estimate your RMR, but a measured number often looks different. A breath test called indirect calorimetry measures how much oxygen you use at rest and gives your RMR from that. Without that baseline, it is hard to know whether the drug is helping or whether you are losing muscle and slowing your metabolism.

    • 02Body composition. A scale is not enough. Before day one, it helps to know how much of someone's weight is lean mass, fat mass, and visceral fat, measured by DEXA or bioelectrical impedance depending on what is available. GLP-1s work partly by reducing total calorie intake. If we do not know how much lean mass someone has at baseline, we cannot tell later whether weight loss is coming from fat or muscle.

    • 03Glucose response patterns. A single fasting glucose reading does not show how someone's metabolism behaves across the day. A period of continuous glucose monitoring before prescribing shows how the person responds to their usual meals, sleep and stress. Some people have normal fasting glucose but clear spikes after meals. Others show the opposite pattern. That affects which molecule makes most sense and what starting dose fits. It also shows which dietary changes will help.

    OUR VIEW

    New metabolic molecules are useful, but the right dose varies between people. Measuring first lets you fit the dose to the person.

    See how we build your baseline

    P.S. If you have already started a GLP-1 without this kind of baseline, hit reply and tell me. I'd like to know what was measured before you began.

    Emilian